Concurrent docetaxel/cisplatin and thoracic radiotherapy for locally advanced non-small cell lung cancer

Tuberculosis and Respiratory Diseases

Volumn 57, Issue 3, 2004, Pages 257-264

  Jang, Tae Won ^a,b   Park, Jung Pil ^a   Kim, Hee Kyoo ^a   Ok, Chul Ho ^a   Jeung, Tae Sig ^a   Jung, Maan Hong ^a  

^a Kosin University College of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

Concurrent chemoradiotherapy; Locally advanced; Non small cell lung cancer

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PNEUMONIA; RADIATION PNEUMONIA; SURVIVAL RATE; SURVIVAL TIME;

EID: 9444223285     PISSN: 03780066     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2004.57.3.257     Document Type: Article

References (27)

1. Ministry of Health and Welfare. Annual report of cancer registry program in the Republic of Korea; 2002.
2. Kim SY. Treatment of Lung Cancer. Korean Academy of Tuberculosis and Respiratory Dieases. Respiratory Diseases. Seoul: Koonja; 2004. p. 621-9.
3. Le Chevalier T, Arriagata R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY, Laplanche A. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-23.
4. Sause W, Kolesar P, Tayer S, Johnson D, Livinston R, Komaki R, Emami B, Curran W jr, Byhardt R, Dar AR, Turrisi A 3rd. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 2000;117:358-64.
5. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer. Cancer 1995;76:593-601.
6. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer. A meta-analysis. Ann Intern Med 1996;125:723-29.
7. Sause W, Kolesar P, Taylor S, Johnson D, livingston R, Komaki R, et al. Final Results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 2000;117:358-64.
8. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-5.
9. Furuse K, Kawahara M, Fukuoka M, Nishikawa H, Takada Y, Kudoh S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999;17:2692-9.
10. Robinson LA, Wagner H Jr., Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003;123:202S-20S.
11. Gandara DR, Lara PN, Goldbergz Lau DH. Integration of new chemotherapeutic agents into chemoradio therapy for stage III non-small cell lung cancer, Semin Oncol 2001;28:26-32.
12. WHO recommendations for grading of acute and subacute toxicity: reporting the results of cancer treatment. Cancer 1981;47:207-14.
13. Scientific committee of Korean academy of tuberculosis and respiratory Diseases: The national survey of lung cancer in Korea. Tuberculosis and Respiratory Diseases 1999;46:455-65.
14. Chung HC, Choi JH, Rho JK, Kim SK, Lee WY, Kim GE: Phase II trial of sequential VP-16, cisplatin combination chemotherapy and radiotherapy for locally advanced (stageIII) non small cell lung cancer. J Korean Cancer Assoc 1991;23(3): 131-9.
15. Schabel FM, Trader MW, Laster WR, Corbett TH, Griswold DP. Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Report 1979;63(2):1459-73.
16. Lee SW, Choi EY, Oh SJ, Suh CW, Kim SW, Lee JS, Kim DS, Kim WD, Lee SD, Kim JH, Kim GJ, Noh YJ. Preliminary results of paclitaxel, cisplatin, and concurrent high-dose radiation therapy for locally advanced non-small-cell lung cancer. Cancer Research and Treatment 2002;34:345-51.
17. Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest 2003;123:221-5.
18. Gandara DR, Chansky K, Albain KS, Leigh BR, Caspar LE, Lara PN Jr, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIb non-small-cell lung cancer. J Clin Oncol 2003;21:2004-10.
19. Kim TE, Murren JR. Therapy for stage IIIb and stage IV non-small cell lung cancer. Clin Chest Med 2002;23:209-24.
20. Milas L. Docetaxel/radiation combinations: rationale and preclinical findings. Clin Lung Cancer 2002;3:S29-36.
21. Wu HG, Bang YJ, Choi EK, Ahn YC, Kim YW, Lim TH, et al. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:75-80.
22. Gandara DR, Lara PN Jr, Goldbergz Lau DH. Integration of new chemotherapeutic agents into chemoradio therapy for stage III non-small cell cancer. Semin Oncol 2001;8:26-32.
23. Janne PA, Skarin AT. Concurrent docetaxel and thoracic radiation in non-small cell lung cancer. Clinical Lung Cancer 2002;3(2):S37-S41.
24. Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hahn SM. Factors affecting the risk of brain metastasis after definitive chemoradiation for locally advanced non-small cell lung cancer. J Clin Oncol 2001;19(5):1344-9.
25. Law A, Karp DD, Dipetrillo T, Daly BT. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced non-small cell lung cancer. Cancer 2001;92:160-4.
26. Choy H, Curran WJ, Scott CB, Bonomi P, Travis P, Haluschak J, Belani CP. Preliminary report of locally advanced multimodality protocol (LAMP). Proc Am Soc Clin Oncol 2002;1160
27. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, de Cremoux H, Doulliard JY, et al. Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991;20:1183-90.